Merck Pharma GmbH & Co. KGaA (quality control testing and batch release)

Ukraine

All drugs from this manufacturer

  • HEPA-MERZ

    The drug is used for the symptomatic treatment of hepatic encephalopathy (in both latent and overt forms).

    Dosage form: concentrate for infusion solution

    Active substance Dosage
    ornithine 5 g/10 ml
    aspartic acid 5 g/10 ml

    ATC: A05BA